The utility and cost of Chlamydia trachomatis and Neisseria gonorrhoeae screening of a male infertility population.

@article{Domes2012TheUA,
  title={The utility and cost of Chlamydia trachomatis and Neisseria gonorrhoeae screening of a male infertility population.},
  author={Trustin S Domes and Kirk C. Lo and Ethan D. Grober and John Brendan M Mullen and Tony Mazzulli and Keith A Jarvi},
  journal={Fertility and sterility},
  year={2012},
  volume={97 2},
  pages={299-305}
}
OBJECTIVE To determine the utility and cost of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) screening in infertile males. DESIGN Cohort study. SETTING Canadian tertiary-level male infertility clinic and university-affiliated laboratories. PATIENT(S) 5,588 male infertility patients. INTERVENTION(S) CT and NG testing on 8,972 urine and semen samples. MAIN OUTCOME MEASURE(S) Prevalence of CT and NG infection in infertile males versus general male population in Canada over 8… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 45 references

Impact of intensified testing for urogenital Chlamydia trachomatis infections: a randomised study with 9-year follow-up

  • B Andersen, I van Valkengoed, I Sokolowski, JK Moller, L Ostergaard, F. Olesen
  • Sex Transm Infect 2011;87:156–61
  • 2011
1 Excerpt

Similar Papers

Loading similar papers…